Revvity Inc (BSP:R1VT34)
R$ 18.52 0 (0%) Market Cap: 63.99 Bil Enterprise Value: 75.85 Bil PE Ratio: 93.84 PB Ratio: 1.78 GF Score: 84/100

PerkinElmer Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 01:30PM GMT
Release Date Price: R$26.39
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Good morning, everyone. This is Derik De Bruin, the senior life sciences and diagnostic tools analyst from Bank of America. Here with my colleague, Mike Ryskin. Welcome to the 2021 virtual Viva Las Vegas Bank of America Healthcare Conference. Thank you for joining us today. We appreciate your participation and attention.

Our next company this morning is PerkinElmer. And with us from Perkin is Prahlad Singh, President and CEO. Prahlad, welcome. Thank you for being here.

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Thank you, Derik.

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

So to set the stage, would you like to make a few opening remarks or I can jump right into the plethora of questions I have for you?

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

I'm sure you do. Good morning, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot